B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough leukemia cases: gentler treatment trial opens for elderly
Disease control Recruiting nowThis study is testing a combination of a targeted cancer drug (inotuzumab ozogamicin) with lower-intensity chemotherapy and immunotherapy for adults with a type of blood cancer called acute lymphoblastic leukemia (ALL). It focuses on patients aged 60 and older, or younger adults …
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 21:41 UTC
-
New hope for adults fighting aggressive leukemia
Disease control Recruiting nowThis study is testing the safety and effectiveness of a new drug, recombinant Erwinia asparaginase, when combined with standard chemotherapy for adults with newly diagnosed, high-risk acute lymphoblastic leukemia or lymphoblastic lymphoma. The trial will enroll 53 adults aged 18-…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New Two-Pronged attack tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing a two-step treatment for a type of blood cancer called B-cell acute lymphoblastic leukemia (ALL). It is for older adults who are newly diagnosed or for adults whose cancer has come back or hasn't responded to other treatments. The treatment first uses a targ…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New drug combo aims to wipe out leukemia in adults
Disease control Recruiting nowThis study is testing a combination of chemotherapy drugs and a newer enzyme-blocking drug (JZP458) to treat adults newly diagnosed with a fast-growing blood cancer called acute lymphoblastic leukemia (ALL). The goal is to see if this combination can eliminate cancer cells more e…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for tough leukemia: adding a targeted drug to standard chemotherapy
Disease control Recruiting nowThis study is testing if adding a targeted drug called tafasitamab to a standard chemotherapy regimen works better for treating adults with a specific type of acute lymphoblastic leukemia (B-ALL). The trial aims to see if this combination can more effectively kill cancer cells an…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC